How Dexamethasone Used in Anti-COVID-19 Therapy Influenced Antihypertensive Treatment in Patients with SARS-CoV-2.

Andrei Puiu Cârstea Adrian Mită Mircea-Catalin FortofoiuIrina Paula DoicaDoina CârsteaCristina Maria BeznăCristina Elena NegroiuIleana-Diana DiaconuAndreea-Roberta GeorgescuAdina Maria KamalBeatrice MahlerAdriana-Gabriela GrigorieGabriel Adrian Dobrinescu

Published in: Healthcare (Basel, Switzerland) (2023)

Dexamethasone for treatment of SARS-CoV-2 infection did not have a notable influence on increasing BP, because the doses were low-moderate and prescribed for a short time.

Keyphrases

sars cov
respiratory syndrome coronavirus
blood pressure
coronavirus disease
high dose
high intensity
cell therapy